CGON
CG Oncology Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
Arthur Kuan
IPO Date
2024-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
CG Oncology Inc.
CEO
Arthur Kuan
IPO Date
2024-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 5,000 |
| $70.00 |
| 25 Jun 2026 | POST LEONARD E | director | M-Exempt | Disposed | 5,000 | $0.60 |
| 23 Jun 2026 | POST LEONARD E | director | M-Exempt | Acquired | 5,000 | $0.60 |
| 23 Jun 2026 | POST LEONARD E | director | S-Sale | Disposed | 5,000 | $65.00 |
| 23 Jun 2026 | POST LEONARD E | director | M-Exempt | Disposed | 5,000 | $0.60 |
| 16 Jun 2026 | Mulay James | director | M-Exempt | Acquired | 654 | $3.72 |
| 16 Jun 2026 | Mulay James | director | S-Sale | Disposed | 1,310 | $60.12 |
| 16 Jun 2026 | Mulay James | director | M-Exempt | Acquired | 1,310 | $12.59 |
| 16 Jun 2026 | Mulay James | director | M-Exempt | Disposed | 654 | $3.72 |